COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

August 28, 2018 00:27:45
Episode Cover

Steroids for Septic Shock - Take 2

In February, we discussed the results of the ADRENAL trial and implications for clinical practice.  Since that time, another large trial and meta-analysis has...

Listen

Episode 0

April 20, 2022 00:20:58
Episode Cover

Low-Tidal Volume Ventilation in the ED - Does it Make a Difference?

Though low-tidal volume ventilation has been shown to decreased mortality in patients with ARDS, the use of these settings in mechanically ventilated ED patients...

Listen

Episode 0

August 29, 2021 00:22:03
Episode Cover

The BaSICS Trial - Implications for Fluid Resuscitation

The administration of IVFs is nearly universal in critically ill patients.  In recent years, several studies have suggested improved outcomes with the use of...

Listen